We are live on ! Find out more
KM

Kalos Management Portfolio holdings

AUM $46.6M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
-13.2%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
AUM
$74.4M
AUM Growth
-$71.7M
Cap. Flow
-$60.1M
Cap. Flow %
-80.7%
Top 10 Hldgs %
34.2%
Holding
182
New
5
Increased
31
Reduced
83
Closed
44

Sector Composition

Rank Sector Weight
1 Miscellaneous 62.69%
2 Real Estate 7.55%
3 Technology 7.1%
4 Financials 6.26%
5 Healthcare 3.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NHI icon
76
National Health Investors
NHI
$3.4B
$292K 0.39%
4,756
-69
-1% -$3.93K
MA icon
77
Mastercard
MA
$502B
$290K 0.39%
914
-218
-19% -$75.1K
AMT icon
78
American Tower
AMT
$82.8B
$287K 0.39%
1,114
-19
-2% -$4.77K
T icon
79
AT&T
T
$183B
$282K 0.38%
13,734
-11,164
-45% -$223K
LLY icon
80
Eli Lilly
LLY
$1.01T
$279K 0.37%
+862
New +$259K
ARCC icon
81
Ares Capital
ARCC
$13.9B
$277K 0.37%
15,361
+1,130
+8% +$22.3K
FDLO icon
82
Fidelity Low Volatility Factor ETF
FDLO
$1.41B
$277K 0.37%
6,022
NKE icon
83
Nike
NKE
$53.7B
$270K 0.36%
2,643
+7
+0.3% +$828
ZTS icon
84
Zoetis
ZTS
$30.3B
$266K 0.36%
1,529
VTR icon
85
Ventas
VTR
$45.4B
$265K 0.36%
5,176
-611
-11% -$34.2K
SCHG icon
86
Schwab US Large-Cap Growth ETF
SCHG
$62.1B
$264K 0.35%
16,944
-1,744
-9% -$27.9K
CNI icon
87
Canadian National Railway
CNI
$73.7B
$263K 0.35%
2,332
CDW icon
88
CDW
CDW
$19.2B
$260K 0.35%
1,659
V icon
89
Visa
V
$701B
$260K 0.35%
1,293
-192
-13% -$39.7K
SPGI icon
90
S&P Global
SPGI
$122B
$258K 0.35%
754
-7
-0.9% -$2.5K
TSLA icon
91
Tesla
TSLA
$1.41T
$258K 0.35%
990
ACN icon
92
Accenture
ACN
$118B
$256K 0.34%
915
BCRX icon
93
BioCryst Pharmaceuticals
BCRX
$2.09B
$256K 0.34%
23,900
+450
+2% +$4.64K
SHW icon
94
Sherwin-Williams
SHW
$78.5B
$254K 0.34%
1,084
+22
+2% +$5.64K
KO icon
95
Coca-Cola
KO
$382B
$252K 0.34%
3,959
-3,768
-49% -$239K
CSGP icon
96
CoStar Group
CSGP
$12.8B
$250K 0.34%
4,000
VEA icon
97
Vanguard FTSE Developed Markets ETF
VEA
$234B
$248K 0.33%
6,083
-1,418
-19% -$63K
PNFP icon
98
Pinnacle Financial Partners Inc
PNFP
$15B
$246K 0.33%
3,339
ACAD icon
99
Acadia Pharmaceuticals
ACAD
$4.61B
$244K 0.33%
17,075
-1,150
-6% -$21.5K
ORGN
100
DELISTED
Origin Materials
ORGN
$243K 0.33%
1,600
-37
-2% -$7.05K

Similar funds

Kalos Management's Q2 2022 Portfolio in Review

As of Q2 2022, Kalos Management held 182 positions worth $74.4M, down 49% from $146M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Kalos Management withdrew a net $60.1M in Q2 2022, closing 44 positions and reducing 83 holdings. Its most notable exit was Destra Multi-Alternative Fund, an estimated $1.95M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, up from 57% a quarter earlier, followed by Real Estate and Technology.

Against the trend, Kalos Management opened a new position in Eli Lilly worth $279K.

  • Kalos Management's largest Q2 2022 buy was Eli Lilly: 862 shares worth $279K.
  • Kalos Management added most to Alphabet (Google) Class C in Q2 2022, an estimated $2.07M increase.
  • Kalos Management's biggest Q2 2022 reduction was Phillips Edison & Co, cutting an estimated $8.69M.
  • Kalos Management fully exited Destra Multi-Alternative Fund in Q2 2022, selling an estimated $1.95M.
  • Kalos Management's ten largest holdings make up 34% of its $74.4M portfolio in Q2 2022.
  • Kalos Management opened 5 new positions and closed 44 in Q2 2022.
  • Kalos Management's portfolio value fell 49% quarter-over-quarter to $74.4M.

Based on Kalos Management's 13F filing for Q2 2022, filed 12 Aug 2022.